Theorem Clinical Research

Venn Life Sciences

Venn Life Sciences acquires French CRO Cardinal Systems

Monday, August 11, 2014 01:42 PM

Venn Life Sciences, a growing CRO providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, has acquired Cardinal Systems, a France-based CRO specializing in data management and randomization systems.

More... »

Quest Diagnostics

Venn Life Sciences Holdings acquires assets of Evocutis

Thursday, February 27, 2014 12:32 PM

CRO Venn Life Sciences has announced the acquisition of the intellectual property rights for Labskin, SYN1113 and related equipment of Evocutis, for $287,000 in new ordinary shares in Venn.

More... »


Venn Life Sciences acquires Medevol

Wednesday, December 11, 2013 11:23 AM

European CRO Venn Life Sciences has acquired Medevol, a CRO based in Northern Ireland, for a total maximum consideration of $1.1 million.

More... »

Venn Life Sciences acquires CRM Clinical Trials

Monday, November 4, 2013 01:37 PM

CRO Venn Life Sciences has signed a conditional agreement to acquire the trade and certain business assets and liabilities of CRM Clinical Trials (CRM), a German-based CRO, for a total consideration of $0.8 million.

More... »

Venn Life Sciences and Encorium to merge

Wednesday, February 22, 2012 01:57 PM

Finland-based CRO Encorium Group and Venn Life Sciences, a provider of development consulting and resourcing services based in Dublin, Ireland, have agreed to merge.

More... »


CWWeekly

March 2

Huntingdon Life Sciences-Harlan prepares for rebranding and U.S. expansion to compete with early phase CROs Covance, CRL

Patients' increased sharing of clinical trial experiences through social media can help sponsors improve outcomes, enrollment

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs